🇺🇸 FDA
Patent

US 10874672

Methods for treating Huntington's disease

granted A61KA61K31/415A61K31/433

Quick answer

US patent 10874672 (Methods for treating Huntington's disease) held by PTC THERAPEUTICS, INC. expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/415, A61K31/433, A61K31/4439, A61K31/4709